T1	Participants 413 520	122 patients with evolving MI to PTCA therapy with or without adjunctive intravenous streptokinase therapy.
T2	Participants 541 724	Patients with ECG ST segment elevation who presented within 4 hours of symptom onset, had no contraindication to thrombolytic therapy, and were not in cardiogenic shock were enrolled.
T3	Participants 1199 1235	106 patients were treated with PTCA.
